Evidence map›Paper›PMID 34382344›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Ten Years of EWAS.

Siyu Wei, Junxian Tao, Jing Xu, Xingyu Chen, Zhaoyang Wang, Nan Zhang, Lijiao Zuo, Zhe Jia, Haiyan Chen, Hongmei Sun and 12 more

Open access · goldAbstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Epigenetics in Abdominal Aortic Aneurysm: Mechanisms and Risk Prediction.medRxiv : the preprint server for health sciences · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 1 country.

Siyu WeiCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Junxian TaoCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Jing XuCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Xingyu ChenCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Zhaoyang WangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Nan ZhangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Lijiao ZuoCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Zhe JiaCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Haiyan ChenCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Hongmei SunCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Yubo YanCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Mingming ZhangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Hongchao LvCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Fanwu KongThe EWAS Project, Harbin, China.
Lian DuanThe EWAS Project, Harbin, China.
Ye MaCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Mingzhi LiaoThe EWAS Project, Harbin, China.
Liangde XuThe EWAS Project, Harbin, China.
Rennan FengThe EWAS Project, Harbin, China.
Guiyou LiuThe EWAS Project, Harbin, China.
The Ewas ProjectThe EWAS Project, Harbin, China.
Yongshuai JiangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.ORCID 0000-0002-7163-6554
Harbin Medical University · CNWenzhou Medical University · CNCapital Medical University · CNHarbin Electric Corporation (China) · CNNorth West Agriculture and Forestry University · CN

Funding

Innovation and Entrepreneurship Training Program for College Students of Heilongjiang Province in 2020 S202010226092XMathematical Tianyuan Fund of the National Natural Science Foundation of China 12026414National Natural Science Foundation of China 31970651National Natural Science Foundation of China 92046018
6 · The paper itself

Abstract

Epigenome-wide association study (EWAS) has been applied to analyze DNA methylation variation in complex diseases for a decade, and epigenome as a research target has gradually become a hot topic of current studies. The DNA methylation microarrays, next-generation, and third-generation sequencing technologies have prepared a high-quality platform for EWAS. Here, the progress of EWAS research is reviewed, its contributions to clinical applications, and mainly describe the achievements of four typical diseases. Finally, the challenges encountered by EWAS and make bold predictions for its future development are presented.

Indexed as

Genetic Predisposition to DiseaseCpG IslandsDNA MethylationEpigenomeGenetic Diseases, InbornGenome-Wide Association StudyHumansSequence AnalysisDNA methylationepigeneticsepigenome-wide association study (EWAS)

Identifiers

PMID34382344
PMCPMC8529436
OpenAlexW3189404898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.